Centerline Biomedical, Inc.

16 articles about Centerline Biomedical, Inc.

• Centerline Biomedical announces New CFO Indrani Egleston

  11/13/2023

  Centerline Biomedical, Inc., an innovator in cardiovascular visualization and navigation systems, announced the appointment of Indrani Egleston to the position of Chief Financial Officer.

• Centerline Biomedical announces Gulam Khan as Chief Executive Officer

  10/4/2022

  Centerline Biomedical, Inc. has appointed Gulam Khan , Chief Executive Officer. 

• 

  Money on the Move: ReCode, MiroBio & More Target Technology

  6/29/2022

  This week money went towards more advanced rounds of financing for drugs and technology that have already shown a lot of promises.

• Centerline Biomedical Raises $33 Million in Series B Financing

  6/27/2022

  Proceeds will accelerate a robust R&D pipeline, commercial partnerships and clinical activities led by leading institutional and strategic investors.

• Centerline Biomedical Announces Successful Structural Heart Animal Study

  5/19/2022

  Centerline Biomedical, Inc. announced Thursday the completion of the second in a series of structural heart navigation animal studies.

• Centerline Biomedical Adds Two Expert Advisors to Advance New Clinical Applications

  6/21/2021

  Centerline Biomedical, Inc., a spinoff of Cleveland Clinic, announced the appointment of two key advisors.

• Centerline Biomedical Appoints Key Physician Thought Leaders and Executives as Advisors

  5/22/2020

  Recruitment of internationally recognized clinical, business, and commercialization experts' bolsters company's strategy and growth plans

• Centerline Biomedical Completes First Human Patient in the United States with IOPS™ (Intra-Operative Positioning System)

  5/4/2020

  Surgical navigation startup Centerline Biomedical, Inc. (Centerline), a Cleveland Clinic spin-off company, has announced the successful completion of the first in a series clinical cases in the US

• Centerline Biomedical Awarded $1.5M Phase II NIH SBIR Grant to Advance Development of Next-Generation IOPS Technology

  4/22/2020

  Surgical navigation startup wins fourth small business award from NIH's National Heart, Lung, and Blood Institute to extend novel technology to address peripheral vascular disease

• Centerline Biomedical Closes $10 Million Financing, Announces Key Appointments and Numerous Corporate Advancements

  3/10/2020

  Centerline Biomedical, Inc. (Centerline), a Cleveland Clinic spinout company, is announcing updates regarding its IOPS™ platform technology designed to improve patient and caregiver safety, reduce procedure time, limit harmful radiation and contrast dye, and overall reduce costs to healthcare systems while improving access to care

• Centerline Biomedical Announces First-in-Human Use of IOPS™ Intra-Operative Positioning System

  11/18/2019

  Centerline Biomedical, Inc., a spinout company from Cleveland Clinic, announced the successful first human clinical use of its groundbreaking IOPS™ technology.

• Centerline Biomedical's Intra-Operative Positioning System Technology Showcased at VIVA Disruptive Technologies Session

  11/11/2019

  Centerline Biomedical, Inc. was one of eleven companies selected to present during the Disruptive Technology for Endovascular Therapy sessions during this year's Vascular InterVentional Advances (VIVA) meeting.

• Centerline Biomedical Receives FDA 510(k) Clearance for Intra-Operative Positioning System

  7/10/2019

   Centerline Biomedical, Inc. (Centerline) has announced that the company has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market its flagship product, the Intra-Operative Positioning System, IOPS.

• Centerline Biomedical Completes Fifth Preclinical Study

  1/4/2018

  This study was the most noteworthy Centerline study to date, demonstrating ability to track sensorized IOPS instruments precisely and efficiently, with enhanced 3-D visualization, without frequent exposure to cancer-causing ionizing radiation associated with current standard of care.

• Centerline Biomedical Rounds Up Successful Year With Series A Fundraising

  12/13/2016

• Centerline Biomedical Successfully Completes Next Set Of Preclinical Studies

  9/7/2016